Download presentation
Presentation is loading. Please wait.
1
Delirium and Its Management
Dimitry Davydow, MD, MPH Assistant Professor University of Washington Department of Psychiatry and Behavioral Sciences
2
Disclosures: - Nothing relevant to disclose Objectives: - To review important clinical aspects of delirium - To discuss pharmacologic management strategies for delirium - To briefly discuss evidence-based non-pharmacologic management strategies
3
Acute Brain Dysfunction AKA Delirium
4
Acute Brain Dysfunction AKA Delirium
Classical Definition: waxing and waning fluctuation in level of consciousness Synonyms: - Acute confusional state - Toxic encephalopathy - ICU psychosis Can occur in all ages, though more common in the elderly Onset is acute or subacute!
5
Acute Brain Dysfunction AKA Delirium
Motoric subtypes: - Agitated/Hyperactive - Lethargic/Hypoactive (most common in ICUs) - Mixed (most common overall) Signs and Symptoms: - * Inattention - Altered levels of consciousness - Impaired memory and orientation - Psychosis: Hallucinations, delusions, thought disorder (Hallucinations and delusions only in about 1/3 of cases) Lots of diagnostic and screening instruments available
6
Acute Brain Dysfunction AKA Delirium
Who is at greatest risk? - The elderly - Patients with “bad brains” (i.e., dementia, TBI, prior strokes) - Post-operative patients - Patients with increasing comorbidities and increasing numbers of medications - Patients with a h/o depression1 - Patients with alcohol dependence (i.e., DTs) McAvay GJ, Van Ness PH, Bogardus ST, et al. Depressive symptoms and the risk of incident delirium in older hospitalized adults. J Am Geriatr Soc 2007;55:
7
Acute Brain Dysfunction AKA Delirium
Why am I calling delirium “acute brain dysfunction?” Because, delirium as a clinical syndrome is a CNS final common pathway of countless medical/surgical etiologic processes. It’s like ARDS of the brain.
8
Acute Brain Dysfunction AKA Delirium
Why is it important to recognize and manage appropriately? - Prolongs hospital length of stay. - Accounts for > $7 billion of Medicare inpatients expenditures. - Associated with short and long-term mortality. - Agitated delirium interferes with patient care and puts patients and staff at risk of harm.
9
Pathophysiology of Delirium
Not fully understood, though theories abound. CNS contributing factors could be excessive neurotransmitter release and abnormal signal conduction, particularly excess striatal dopamine and underactivity of muscarinic neurons in the cortex, reticular activating system and hippocampus. Pro-inflammatory cytokines crossing the blood-brain barrier are also thought to play a important role.
11
Most Important Management Aspects
Recognize the problem Figure out what the underlying cause is (e.g., med, infection, new stroke, electrolyte problem, profound anemia) and fix it
12
Common Pharmacologic Risk Factors
Anticholinergic medications: - Diphenhydramine, Hydroxyzine - Ipatropium - Many tricyclic antidepressants (e.g., Amitriptyline) - Paroxetine - Many synthetic opioids (e.g., Fentanyl) - Ranitidine/Cimetidine - Oxybutynin - Benztropine - Prochlorperazine, Promethazine - Cyproheptadine
13
Common Pharmacologic Risk Factors
More common anticholinergic medications: - Digoxin - Nifedipine - Furosemide - Dicyclomine - Diphenoxylate atropine - Chlorpromazine - Olanzapine
14
Common Pharmacologic Risk Factors
Benzodiazepines - Both intoxication and withdrawal Opioids Fluoroquinolone antibiotics Corticosteroids
15
Other Toxin Risk Factors
Alcohol intoxication and withdrawal Barbiturate intoxication and withdrawal MDMA Ketamine PCP LSD Cocaine/Methamphetamines Solvents
16
Other Etiologies of Delirium
Metabolic conditions - Electrolyte disturbances: hypoglycemia, hyperglycemia, hyponatremia, hypernatremia, hypercalcemia, hypocalcemia, hypomagnesemia - Hypothermia and hyperthermia - Dehydration and malnutrition Respiratory failure: hypoxemia and hypercarbia Liver failure/hepatic encephalopathy Renal failure/uremia
17
Other Etiologies of Delirium
Heart failure Vitamin deficiencies: B12, thiamine (B1), folate, niacin (B3) Anemia Infections - Systemic infections/sepsis - Urinary tract infections (in elderly, dementias, TBI) - Pneumonia - Skin and soft tissue infections - CNS infections: meningitis, encephalitis, brain abscess
18
Other Etiologies of Delirium
Endocrine conditions - Hyperthyroidism/hypothyroidism - Hyperparathyroidism - Adrenal insufficiency Cerebrovascular disorders - Global hypoperfusion states - Hypertensive encephalopathy - Focal ischemic strokes and hemorrhages: especially nondominant parietal and thalamic lesions
19
Other Etiologies of Delirium
Autoimmune disorders - CNS vasculitis - CNS Lupus Seizure-related disorders - Nonconvulsive status epilepticus - Intermittent seizures with prolonged post-ictal states Neoplastic disorders - Diffuse metastases to the brain - Gliomatosis cerebri - Carcinomatous meningitis - Hematologic malignancies
20
Other Etiologies of Delirium
Hospitalization (or other environmental change in demented) Severe insomnia Severe pain Constipation Terminal end-of-life delirium
21
Reminder: Most Important Management Aspects
Recognize the problem Figure out what the underlying cause is (e.g., med, infection, new stroke, electrolyte problem, profound anemia) and fix it
22
Pharmacologic Management Strategies
Antipsychotics Other: - Dexmedetomidine - Melatonin - Benzodiazepines ?
23
Antipsychotics for Delirium
24
Important Consideration
Treating delirium with a medication means treating symptoms No evidence that antipsychotics make a delirious patient “not delirious” Only figuring out the underlying cause and fixing it will make a delirious patient “not delirious” Antipsychotic management is temporary
25
Haloperidol
26
Haloperidol Butyrophenone derivative
Mechanism of action: blockade of D2 receptors in mesocortex and limbic system “High potency” antipsychotic Available PO/IM/IV IV form is treatment of choice for agitated delirium IV haloperidol: onset within seconds; duration 4-6 hours Hepatically metabolized; renal and biliary excretion
27
Haloperidol Unfortunately, no RCTs w/ IV haloperidol in delirium
Best haloperidol delirium study to date: - 244 delirious patients with HIV/AIDS randomized (double-blind) to haloperidol (PO) vs. chlorpromazine (PO) vs. lorazepam (PO); only haloperidol group improved while other 2 worsened1 Breitbart W, Marotta R, Platt MM, et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996;153:
28
Haloperidol Side effects/Adverse events: - EPS: less common w/ IV than PO/IM; akathesia is a concern: - Avoid in patients w/ Parkinson’s disease - QTc prolongation and Torsades Des Pointes: - QTc prolongation is a class-related phenomenon - Most patients w/ QT prolongation and Torsades while on IV haloperidol have additional risk factors for these cardiac events1 - Check baseline EKG and monitor frequently w/ regular use; replete Mg++ and K+ - Neuroleptic Malignant Syndrome: - Typically in high doses w/ rapid escalation of dosing Meyer-Massetti C, Cheng CM, Sharpe BA, Meier CR, Guglielmo BJ. The FDA extended warning for intravenous haloperidol: how should institutions respond? J Hosp Med 2010;5:E8-E16
29
Haloperidol Dosing considerations: - No evidence-base
- Dosing based on patient size, age, history of antipsychotic exposure - Begin 1-2mg IV q 4 hrs PRN - If requiring frequent PRNs, schedule dosing - If severely agitated and minimal other risk factors, can give 5mg IV q minutes over 1 hour, then schedule q 6 hrs - Have a ceiling: 100mg/24 hrs is a pretty good one
30
Atypical Antipsychotics
Quetiapine
31
Quetiapine Lowest potency atypical antipsychotic
Mechanism of action: less potent blockade of D2 receptors, also blocks 5HT receptors; also blocks α1 and H1 receptors Only available PO Half-life: 6 hours Hepatically metabolized; renally excreted
32
Quetiapine One double-blind RCT of quetiapine for delirium:1
- Found its “safe and effective” - Only 36 patients - Doses beginning at 50mg q 12 hrs up to 200mg q 12 hrs - Both groups got IV haloperidol as “rescue” Dosing considerations: - No evidence base - If using, would begin at 50mg q 12 hrs w/ 50mg q 4 hrs PRN (adjust if elderly, renal failure) Devlin JW, Roberts RJ, Fong JJ, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter. Randomized, double-blind, placebo controlled pilot study. Crit Care Med 2010;38:
33
Quetiapine Side effects/Adverse Events: Other issues: - Expensive
- Sedation - Orthostatic hypotension - At high doses (800mg per day), has significant anticholinergic effects - QTc prolongation and NMS are still concerns Other issues: - Expensive - At doses below 50mg, primarily only an H1 blocker
34
Atypical Antipsychotics
Risperidone
35
Risperidone Mechanism of action: highest potency atypical D2 blocker; also blocks 5HT receptors Available PO as tablet, dissolvable tablet, liquid Half-life is 3-20 hours depending on formulation Hepatically metabolized; renally excreted
36
Risperidone One very small RCT found risperidone equal to haloperidol PO for delirium in the ICU1 Dosing considerations: - No evidence base - If using, can start at 0.5-1mg PO q 12 hrs w/ 0.5mg q 4 hrs PRN (adjust for elderly, renal failure) Side effects/Adverse Events: - EPS - Sedation - QTc prolongation; NMS 1. Han CS, Kim YK. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004;45:
37
Other Atypical Antipsychotics
Olanzapine: - Available PO as tablet or dissolvable tab; also IM - Problem: highly anticholinergic once going over 15 mg total Ziprasidone: - Problem: greatest risk of QTc prolongation Aripiprazole: - Problem: half-life 75 hours All are expensive Data for use in delirium minimal to none
38
Antipsychotics for Delirium
Is there evidence that antipsychotics can prevent delirium? - 3 studies with elective hip surgery patients; 2 studies w/ haloperidol and 1 w/ olanzapine pre-op; mixed results - Jury is still out
39
Antipsychotics for Delirium – Final Thoughts
Treating the symptoms: - Agitated, hyperactive delirium - Hypoactive delirium but psychotic symptoms present that are bothering the patient Class-related issues: - QTc prolongation, NMS, FDA black box warning for risk of death due to cerebrovascular events in elderly w/ dementia Temporary measure: - Have a taper schedule
40
Other Pharmacologic Agents for Delirium
41
Dexmedetomidine Sedative agent for intra-operative and ICU sedation while intubated Mechanism of action: central α2 agonist IV only Half-life: 3 hours Hepatically metabolized; renally excreted
42
Dexmedetomidine No RCT evidence to support use to treat delirium in ICU settings - One open label study showed promising results for dex drip vs. haloperidol drip in intubated, delirious ICU patients1 Can consider for agitated, delirious, critically ill patients refractory to other agents Dosing: - Loading infusion of up to 1mcg/kg/min over 10 min - Maintenance: mcg/kg/hr - Adjust downward in elderly Reade MC, O’Sullivan K, Bates S, et al. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open- label trial. Crit Care 2009;13:R75
43
Dexmedetomidine Side effects/Adverse events: - Bradycardia
- Hypotension - Transient hypertension Other issues: - Cost: ($55 per 100mcg/mL in 2mL vial VS. $5 per 5mg midazolam vial)
44
Melatonin Insomnia may play an important role in potentiating delirium
Disturbance in metabolism of tryptophan-derived compounds may play role in delirium Emerging evidence to support use of melatonin 0.5mg at bedtime for treatment and possible prevention of delirium1 Larger-scale RCTs are needed Al-Aama T, Brymer C, Gutmanis I, et al. Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial. Int J Geriatr Psychiatry 2011;26:
45
Benzodiazepines? Only use benzos for delirium if it’s DTs or benzodiazepine withdrawal-related delirium Otherwise, you will make it worse In patients w/ cirrhosis or other hepatic insufficiency and DTs, use lorazepam or oxazepam (no active hepatic metabolite) For barbiturate withdrawal-related delirium, use phenobarbitol (initial loading dose than taper)
46
Non-pharmacologic Management of Delirium
3 Rs (Reorientation, Reassurance, Reinforce normal sleep-wake cycle) Restraints if necessary to keep patient and staff safe 1:1 observer Enlist family to help with 3 Rs as much as possible Early mobilization
47
Summary The keys to managing delirium are to recognize it and fix the underlying problem Antipsychotics may treat symptoms (e.g., agitation, psychosis), but they won’t cure delirium Consider non-pharmacologic options to help manage delirious patients
48
The End
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.